DIFFUSE UVEAL MELANOCYTIC PROLIFERATION

DIFFUSE UVEAL MELANOCYTIC PROLIFERATION was reported 19 times

DIFFUSE UVEAL MELANOCYTIC PROLIFERATION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 DORZOLAMIDE HCL 1 0.0009
1 CEMIPLIMAB-RWLC 1 0.0005
2 DURVALUMAB 6 0.0003
3 LOTEPREDNOL ETABONATE 1 0.0002
4 DORZOLAMIDE 1 0.0001
5 TRAVOPROST 1 0.0001
6 PEMBROLIZUMAB 8 0.0001
7 NINTEDANIB 2 0.0001
8 BRIMONIDINE TARTRATE 1 0.0001
9 CALCITRIOL CAPSULES 0.25 MCG 1 0.0000
10 SODIUM BICARBONATE INJECTION, 1 0.0000
11 LINACLOTIDE 1 0.0000
12 ERGOCALCIFEROL 1 0.0000
13 CETUXIMAB 1 0.0000
14 SUNITINIB MALATE 1 0.0000
15 MAGNESIUM OXIDE 1 0.0000
16 IPILIMUMAB 1 0.0000
17 PACLITAXEL 2 0.0000
18 BEVACIZUMAB 2 0.0000
19 CARBOPLATIN 2 0.0000
20 CALCIUM CARBONATE 1 0.0000
21 EZETIMIBE 1 0.0000
22 DOXORUBICIN 1 0.0000
23 NIVOLUMAB 1 0.0000
24 WARFARIN 1 0.0000
25 TACROLIMUS OINTMENT 0.1% 1 0.0000
26 TACROLIMUS EXTENDED-RELEASE CAPSULES 1 0.0000
27 VENLAFAXINE HYDROCHLORIDE 1 0.0000
28 MYCOPHENOLATE MOFETIL 1 0.0000
29 MYCOPHENOLATE MOFETIL HYDROCHLORIDE 1 0.0000
30 ESCITALOPRAM 1 0.0000
31 TACROLIMUS 1 0.0000
32 ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE 1 0.0000
33 METOPROLOL TARTRATE 1 0.0000
34 GABAPENTIN 1 0.0000
35 OMEPRAZOLE MAGNESIUM 1 0.0000
36 ACETAMINOPHEN 1 0.0000
37 PREDNISONE 1 0.0000